Search Results

You are looking at 1 - 4 of 4 items for :

  • ACTH-secreting PitNET x
Clear All
Erika Peverelli Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Erika Peverelli in
Google Scholar
PubMed
Close
,
Donatella Treppiedi Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Donatella Treppiedi in
Google Scholar
PubMed
Close
, and
Giovanna Mantovani Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Milan, Italy

Search for other papers by Giovanna Mantovani in
Google Scholar
PubMed
Close

Introduction Adrenocorticotropic hormone (ACTH)-secreting pituitary neuroendocrine tumors (PitNETs) are the cause of Cushing’s disease (CD), a rare and potentially fatal systemic condition due to chronic exposure to cortisol, that results in

Open access
Donatella Treppiedi Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Donatella Treppiedi in
Google Scholar
PubMed
Close
,
Rosa Catalano Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Rosa Catalano in
Google Scholar
PubMed
Close
,
Federica Mangili Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Search for other papers by Federica Mangili in
Google Scholar
PubMed
Close
,
Giovanna Mantovani Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Search for other papers by Giovanna Mantovani in
Google Scholar
PubMed
Close
, and
Erika Peverelli Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Search for other papers by Erika Peverelli in
Google Scholar
PubMed
Close

(SSTR5), the main pharmacology targets of prolactin (PRL)-, growth hormone (GH)- and adrenocorticotropic hormone (ACTH)-secreting PitNETs, respectively. In this scenario, FLNA plays a pivotal role in determining the antitumoral action of dopaminergic and

Open access
Sylvia L Asa Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by Sylvia L Asa in
Google Scholar
PubMed
Close
and
Shereen Ezzat Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Shereen Ezzat in
Google Scholar
PubMed
Close

therapeutic response ( Table 1 ). Table 1 Classification of PitNETs. Family Tumor type Tumor subtype Transcription factor(s) Hormones Other biomarkers TPIT Corticotroph Densely granulated TPIT ACTH Keratins

Open access
Nele F Lenders Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Nele F Lenders in
Google Scholar
PubMed
Close
,
Peter E Earls Department of Anatomical Pathology and Cytopathology, St Vincent’s Pathology, Sydney, NSW, Australia

Search for other papers by Peter E Earls in
Google Scholar
PubMed
Close
,
Warrick J Inder Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia
Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia

Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Close
, and
Ann I McCormack Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia

Search for other papers by Ann I McCormack in
Google Scholar
PubMed
Close

sella region such as craniopharyngiomas or meningiomas. The authors have chosen not to discuss the proposed nomenclature change from ‘pituitary adenoma’ to ‘PitNET’, as described in the WHO 2022 classification, as this is the subject of significant

Open access